Article
Deep mutational scanning identifies SARS-CoV-2 Nucleocapsid escape mutations of currently available rapid antigen tests.
Cell - 15 Sept 2022
Frank Filipp, Keen Meredith M, Rao Anuradha, Bassit Leda, Liu Xu, Bowers Heather B, Patel Anamika B, Cato Michael L, Sullivan Julie A, Greenleaf Morgan, Piantadosi Anne, Lam Wilbur A, Hudson William H, Ortlund Eric A
Abstract excerpt
The effects of mutations in continuously emerging variants of SARS-CoV-2 are a major concern for the performance of rapid antigen tests. To evaluate the impact of mutations on 17 antibodies used in 11 commercially available antigen tests with emergency use authorization, we measured antibody binding for all possible Nucleocapsid point mutations using a mammalian surface-display platform and deep mutational...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
